Your session is about to expire
← Back to Search
Study Summary
This trial will test a new suicide prevention app to see if it's safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 26 years old.
- Group 1: Mobile Application to Prevent Suicide (MAPS)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Do individuals of a younger age meet the eligibility requirements for this experiment?
"Prerequisites for entry into this trial necessitates that participants are within the 18-26 age range. There is a separate 84 study selection process for those below 18 and 156 studies available to individuals over 65 years of age."
Who should consider participating in this research study?
"This investigation requires 40 participants between 18 to 26 years old with a history of suicidal ideation. To be eligible, they need to be sufficiently stable for study participation, at the specified age range and conversant in smartphone technology."
Are there currently vacancies for participants in this clinical research?
"Per the information on clinicaltrials.gov, this experiment is no longer accepting candidates. Initially posted in October of 2022 and concluding on August 19th 2022, it has since concluded its recruiting phase. However, there remain 244 other trials currently enrolling participants."
Share this study with friends
Copy Link
Messenger